Table 3.
Comparison of small vessel disease MRI findings.
| All | with BPS | without BPS | p value | |
|---|---|---|---|---|
| n = 42 | n = 15 | n = 27 | ||
| SVD MRI findings | ||||
| Number of lacunar infarcts (n) | 0.6 ± 1.2 | 0.7 ± 1.6 | 0.5 ± 1.0 | 0.544 |
| WMH | ||||
| Periventricular (Fazekas) | 1.9 ± 1.2 | 1.3 ± 1.2 | 1.7 ± 1.1 | 0.371 |
| Deep (Fazekas) | 1.5 ± 1.1 | 1.7 ± 1.3 | 2.0 ± 1.1 | 0.489 |
| Total Number of CMBs (n) | 5.1 ± 9.0 | 5.9 ± 6.9 | 4.7 ± 10.1 | 0.001* |
| Number of Lobar CMBs (n) | 4.5 ± 8.1 | 4.9 ± 5.8 | 4.1 ± 9.3 | 0.001* |
| Number of Deep CMBs (n) | 0.7 ± 1.8 | 1.0 ± 2.4 | 0.5 ± 1.1 | 0.442 |
| Number of CMIs (n) | 1.0 ± 2.4 | 0.1 ± 0.3 | 0.1 ± 0.3 | 0.642 |
| Number of cSS (n) | 1.0 ± 2.4 | 0.1 ± 0.4 | 0.1 ± 0.6 | 0.277 |
| SVD score and each point | ||||
| Total-SVD score | 2.3 ± 1.2 | 2.3 ± 1.2 | 2.2 ± 1.2 | 0.745 |
| Lacunar infarcts (0–1) | 0.3 ± 0.5 | 0.3 ± 0.5 | 0.3 ± 0.5 | 1.000 |
| CMBs (0–1) | 0.7 ± 0.5 | 0.9 ± 0.4 | 0.6 ± 0.5 | 0.163 |
| Basal ganglia PVS (0–1) | 0.6 ± 0.5 | 0.5 ± 0.5 | 0.6 ± 0.5 | 0.547 |
| WMH (0–1) | 0.6 ± 0.5 | 0.6 ± 0.5 | 0.6 ± 0.5 | 0.852 |
| CAA-SVD score | 2.3 ± 1.3 | 2.7 ± 1.2 | 2.0 ± 1.2 | 0.096 |
| Lobar CMBs (0–2) | 0.8 ± 0.8 | 1.2 ± 0.7 | 0.6 ± 0.8 | 0.029* |
| cSS (0–2) | 0.1 ± 0.3 | 0.1 ± 0.4 | 0.0 ± 0.2 | 0.251 |
| Centrum semiovale PVS (0–1) | 0.7 ± 0.5 | 0.7 ± 0.5 | 0.7 ± 0.5 | 0.841 |
| Modified CAA-SVD score | 2.5 ± 1.3 | 3.0 ± 1.1 | 2.2 ± 1.4 | 0.046* |
| Posterior distribution of WMH (0–1) | 0.2 ± 0.4 | 0.3 ± 0.5 | 0.1 ± 0.3 | 0.200 |
| CMIs due to CAA (0–1) | 0.1 ± 0.3 | 0.1 ± 0.3 | 0.1 ± 0.3 | 0.642 |
BPS, Behavioral and psychological symptoms; CAA, Cerebral amyloid angiopathy; CMBs, Cerebral microbleeds; CMIs, Cortical microinfarcts; cSS, Cortical superficial siderosis; MRI, Magnetic resonance imaging; PVS, Enlargement of perivascular spaces; SVD, small vessel disease; WMH, White matter hyperintensities.
*Differences with p < 0.05 was considered statistically significant.